MedPath

Intrauterine Contraceptive Device (IUD) Placement at Time of C-Section

Phase 4
Completed
Conditions
Contraception
Registration Number
NCT00733278
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Brief Summary

This is a pilot study of up to 10 women, which will test the hypothesis that the placement of copper IUDs through the uterine incision at the time of uncomplicated elective C-section is technically feasible and acceptable to women seeking long-term contraception.

Detailed Description

Women will be enrolled in this study during late prenatal care. Consent for placement of the IUD will be verified prior to elective C-section. After removal of the placenta, the copper IUD will be placed through the incision at the fundus and the tail strings will be delivered through the cervix. Data will be collected about patient bleeding and possible infection during the immediate postoperative period. The visibility of the strings will be verified at discharge and at 2 and 6 weeks postpartum. Fundal placement of the IUD will be verified by ultrasound at the patient's last visit.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
7
Inclusion Criteria
  • Pregnant woman
  • Requires elective C-section
  • Desires long-term contraception
Exclusion Criteria
  • Contraindications to copper IUD

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Successful Retention of IUD6 weeks
Secondary Outcome Measures
NameTimeMethod
Visibility Within the Vagina of IUD Strings at All Times.At 3 days, 2 weeks and 6 weeks postpartum

Trial Locations

Locations (1)

Los Angeles BRI

🇺🇸

Torrance, California, United States

Los Angeles BRI
🇺🇸Torrance, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.